The internist's role in managing diabetic retinopathy: Screening for early detection

Cleveland Clinic Journal of Medicine

Volumn 71, Issue 2, 2004, Pages 151-159

  Sinclair, Stephen H ^a   Delvecchio, Cherie ^b  

^a CROZER CHESTER MEDICAL CENTER   (United States)

^b PENNSYLVANIA COLLEGE OF OPTOMETRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSE REDUCTASE INHIBITOR; AMINOGUANIDINE; ANTIDIABETIC AGENT; ANTIHISTAMINIC AGENT; INSULIN; METFORMIN; PROTEIN KINASE C INHIBITOR;

BLINDNESS; CONTINUING EDUCATION; DIABETIC MICROANGIOPATHY; DIABETIC RETINOPATHY; DISEASE SEVERITY; DOCTOR PATIENT RELATION; EARLY DIAGNOSIS; EYE PHOTOGRAPHY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTERNAL MEDICINE; INTERPERSONAL COMMUNICATION; LOW LEVEL LASER THERAPY; MEDICAL SPECIALIST; NON INSULIN DEPENDENT DIABETES MELLITUS; OPHTHALMOLOGY; PATHOPHYSIOLOGY; PATIENT COMPLIANCE; PHYSICIAN ATTITUDE; PRIMARY MEDICAL CARE; RETINA EXAMINATION; REVIEW; SCREENING TEST; TEAMWORK; TREATMENT FAILURE; TREATMENT OUTCOME; VISION; VISUAL IMPAIRMENT; VISUAL SYSTEM EXAMINATION; VITRECTOMY;

EID: 1342268319     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.71.2.151     Document Type: Review

References (65)

1. Aiello L, Gardner T, King G, et al. Diabetic retinopathy. Technical review. Diabetes Care 1998; 21:143-156.
2. Masuda M, Murakami T, Egawa H, Murata K. Decreased fluidity of polymorphonuclear leukocyte membrane in streptozocin-induced diabetic rats. Diabetes 1990; 39:466-470.
3. Bohlen H, Hankins K. Early arteriolar and capillary changes in streptozotocin-induced diabetic rats and intraperitoneal hyperglycaemic rats. Diabetologia 1982; 22:344-348.
4. Wierusz-Wysocka B, Wysocki H, Siekierka H, et al. Evidence of polymorphonuclear neutrophils activation (PMN) in patients with insulin-dependent diabetes mellitus. J Leukocyte Biol 1987; 47:519-523.
5. Schroder S, Palinski W, Schmid-Schonbein G. Activated monocytes and granulocytes, capillary nonperfusion, and neovascularization in diabetic retinopathy. Am J Pathol 1991; 139:81-100.
6. Barouch F, Miyamoto K, Allport J, et al. Integrin-mediated neutrophil adhesion and retinal leukostasis in diabetes. Invest Ophthalmol Vis Sci 2000; 41:1153-1158.
7. Sinclair S. Macular retinal capillary hemodynamics in diabetic patients. Ophthalmology 1991; 98:1580-1586.
8. Grunwald J, Riva C, Brucker J, et al. Retinal blood flow in diabetes mellitus. Ophthalmology 1986; 93:590-595.
9. Boulton M, Foreman D, Williams G, McLeod D. VEGF localization in diabetic retinopathy. Br J Ophthalmol 1998; 82:561-568.
10. Miyamoto K, Khosrof S, Bursell S, et al. Vascular endothelial growth factor (VEGF)-induced retinal vascular permeability is mediated by intercellular adhesion molecule-1 (ICAM-1). Am J Pathol 2000; 156:1733-1739.
11. Funatsu H, Yamashita H, Ikeda T, et al. Angiotensin II and vascular endothelial growth factor in the vitreous fluid of patients with diabetic macular edema and other retinal disorders. Am J Ophthalmol 2002; 133:537-543.
12. Benjamin L. Glucose, VEGF-A, and diabetic complications. Am J Pathol 2001; 158:1181-1184.
13. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study Report Number 1. Arch Ophthalmol 1985; 103:1796-1806.
14. Sinclair SH, Alaniz R, Presti P. Laser treatment of diabetic macular edema: comparison of ETDRS-level treatment with threshold-level treatment by using high-contrast discriminant central visual field testing. Semin Ophthalmol 1999; 14:214-222.
15. Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS report number 8. Ophthalmology 1981; 88:583-600.
16. Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe vitreous hemorrhage in diabetic retinopathy: four-year results of a randomized trial: diabetic retinopathy study report 5. Arch Ophthalmol 1990; 108:958-964.
17. Diabetic Retinopathy Vitrectomy Study Research Group. Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Results of a randomized trial. DRVS report no. 3. Ophthalmology 1988; 95:1307-1320.
18. Gandorfer A, Messmer EM, Ulbig MW, Kampik A. Resolution of diabetic macular edema after surgical removal of the posterior hyaloid and the inner limiting membrane. Retina 2000; 20:126-133.
19. Giovannini A, Amato G, Mariotti C, Scassellati-Sforzolini B. Optical coherence tomography findings in diabetic macular edema before and after vitrectomy. Ophthalmic Surg Lasers 2000; 31:187-191.
20. Yang CM. Surgical treatment for severe diabetic macular edema with massive hard exudates. Retina 2000; 20:121-125.
21. Jaffe GJ, Yang CH, Guo H, Denny JP, Lima C, Ashton P. Safety and pharmacokinetics of an intraocular fluocinolone acetonide sustained delivery device. Invest Ophthalmol Vis Sci 2000; 41:3569-3575.
22. Jaffe G, Ashton P. A multicenter, randomized, masked, controlled study to evaluate Retisert, an intravitreal fluocinolone acetonide implant, in the treatment of patients with diabetic macular edema. Control Delivery Systems, 2001; v. 2001.
23. Diabetes Control and Complications Trial Research Group (DCCT). The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993; 329:977-986.
24. United Kingdom Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352:837-853.
25. Klein R, Moss S, Klein B. New management concepts for timely diagnosis of diabetic retinopathy treatable by photocoagulation. Diabetes Care 1987; 10:633-638.
26. Klein R, Klein B. Vision disorders in diabetes. In: Group NDD, editor. Diabetes in America, 2nd ed. Bethesda, Md.: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Disease, 1995; v. NIH publication 95-1468.
27. Sorbinil Retinopathy Trial Research Group. A randomized trial of sorbinil, an aldose reductase inhibitor in diabetic retinopathy. Arch Ophthalmol 1990; 108:1234-1244.
28. Tromp A, Hooymans J, Barendsen B, van Doormaal J. The effects of an aldose reductase inhibitor on the progression of diabetic retinopathy. Doc Ophthalmol 1991; 78:153-159.
29. Boel E, Selmer J, Flodgaard HJ, Jensen T. Diabetic late complications: will aldose reductase inhibitors or inhibitors of advanced glycosylation endproduct formation hold promise? J Diabetes Complications 1995; 9:104-129.
30. Frank R. Potential new medical therapies for diabetic retinopathy: protein kinase C inhibitors. Am J Ophthalmol 2002; 133:693-698.
31. Mokhad AH, Ford ES, Bowman BA, et al. Diabetes trends in the U.S.: 1990-1998. Diabetes Care 2000; 23:1278-1283.
32. American Diabetes Association. Implications of the diabetes control and complications trial. Clin Diabetes 1993; 11:91-96.
33. Williams R. Diabetes mellitus. In: Stevens A, Raftery J, editors. Health Care Needs Assessment. New York: Oxford University Press, 1994.
34. Klein R. Barriers to prevention of vision loss caused by diabetic retinopathy [editorial]. Arch Ophthalmol 1997; 115:1073-1074.
35. Agardh E, Arardh C-D, Hansson-Lundblad C. The 5-year incidence of blindness after introducing a screening programme for early detection of treatable diabetic retinopathy. Diabet Med 1993; 10:555-559.
36. Porta M, Tomalino MG, Santoro F, et al. Diabetic retinopathy as a cause of blindness in the province of Turin, north-west Italy, in 1967-1991. Diabet Med 1995; 12:355-361.
37. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 1994; 17:616-623.
38. American Academy of Ophthalmology. Diabetic Retinopathy: Preferred Practice Pattern. San Francisco, Calif, 1989.
39. American Optometric Association. Guidelines for Optometric Care of Patients with Diabetes Mellitus. St Louis, 1994.
40. Schoenfeld E, Greene JM, Wu SY, Leske C. Patterns of adherence to diabetes vision care guidelines: baseline findings from the Diabetic Retinopathy Awareness Program. Ophthalmology 2001; 108:563-571.
41. Brechner R, Cowie C, Howie L, et al. Ophthalmic examination among adults with diagnosed diabetes mellitus. JAMA 1993; 270:1714-1718.
42. Weiner J, Parente S, Garnick D, et al. Variation in office-based quality: a claim-based profile of care provided to Medicare patients with diabetes. JAMA 1995; 273:1503-1508.
43. Moss S, Klein R, Klein B. Factors associated with having eye examinations in persons with diabetes. Arch Fam Med 1995; 4:529-534.
44. Mukamel D, Bresnick G, Wang Q, Dickey C. Barriers to compliance with screening guidelines for diabetic retinopathy. Ophthalmic Epidemiol 1999; 6:61-72.
45. McCarty C, Lloyd-Smith C, Lee S, et al. Use of eye care services by people with diabetes: the Melbourne Visual Impairment Project. Br J Ophthalmol 1998; 82:410-414.
46. Donovan J. Patient decision making: the missing ingredient in compliance research. Int J Tech Assessment Health Care 1995; 11:443-55.
47. Kraft S, Marrero D, Lazaridis E, et al. Primary care physicians' practice patterns and diabetic retinopathy: current levels of care. Arch Fam Med 1997; 6:29-37.
48. Jacques C, Jones R, Houts P, et al. Reported practice behaviors for medical care of patients with diabetes mellitus by primary-care physicians in Pennsylvania. Diabetes Care 1991; 14:712-717.
49. Wender R. Preventive health care for diabetics: a realistic vision. Arch Fam Med 1997; 6:38-41.
50. Steinmann W, Sinclair S, Holmes J, et al. Retinopathy in diabetics at first ophthalmologic visit [abstract]. Invest Ophthalmol Vis Sci 1986; 27(suppl):4.
51. Will J, German R, Schurman E, Michael S, Kurth DM, Deeb L. Patient adherence to guidelines for diabetes eye care: results from the Diabetic Eye Disease Follow-up Study. Am J Public Health 1990; 84:1669-1671.
52. Steinmann W, Garnder M, O'Sullivan R, et al. Provision of ophthalmic care by primary care providers. Submitted.
53. Millstein M, Sinclair S, Steinmann W. Pupillary dilation with tropicamide 1%. Ann Intern Med 1987; 107:181-184.
54. Sussman E, Tsiaras W, Soper K. Diagnosis of diabetic eye disease. JAMA 1982; 247:3231-3234.
55. Jacobs D. Teaching doctors about the eye: trends in the education of medical students and primary care residents. Surv Ophthalmol 1998; 42:383-389.
56. O'Hare J, Hopper A, Madhaven C, et al. Adding retinal photography to screening for diabetic retinopathy: a prospective study in primary care. BMJ 1996; 312:679-682.
57. Moss S, Klein R, Kressler S, Richie K. Comparison between ophthalmoscopy and fundus photography in determining severity of diabetic retinopathy. Ophthalmology 1985; 92:62-67.
58. Lin DY, Blumenkranz MS, Brotheres RJ, Grosvenor DM. The sensitivity of single-field nonmydriatic monochromatic digital fundus photography with remote image interpretation for diabetic retinopathy screening: a comparison with ophthalmoscopy and standardized mydriatic color photography. Am J Ophthalmol 2002; 134:204-213.
59. Lim J, LaBree L, Nicholes T, Gardenas I. A comparison of digital nonmydriatic fundus imaging with standard 35-millimeter slides for diabetic retinopathy. Ophthalmology 2000; 107:866-976.
60. Gomez-Ulla F, Fernandez M, Gonzalez F, et al. Digital retinal images and teleophthalmology for detecting and grading diabetic retinopathy. Diabetes Care 2002; 25:1384-1389.
61. Bursell SE, Cavallerano JD, Cavallerano AA, et al. Stereo nonmydriatic digital-video color retinal imaging compared with Early Treatment Diabetic Retinopathy Study seven standard field 35-mm stereo color photos for determining level of diabetic retinopathy. Ophthalmology 2001; 108:572-585.
62. Klein R, Klein B. Screening for diabetic retinopathy, revisited: editorial. Am J Ophthalmol 2002; 134:261-263.
63. Cohen S, Halvorsen H, Gosselink C. Changing physician behavior to improve disease prevention. Prev Med 1994; 23:284-291.
64. Dickey L, Kamerow D. The "Put Prevention into Practice" campaign: office tools and beyond. J Fam Pract 1994; 39:321-323.
65. Manley M, Eppos R, Husten C, et al. Clinical interventions in tobacco control: a National Cancer Institute training program for physicians. JAMA 1991; 226:3172-3173.